Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited (FPH.AX) Stock Competitors & Peer Comparison
See (FPH.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FPH.AX | A$31.75 | -0.63% | 18.6B | 52.05 | A$0.61 | +1.31% |
| RMD.AX | A$32.83 | -0.42% | 47.8B | 23.12 | A$1.42 | +1.06% |
| ANN.AX | A$29.84 | +0.30% | 4.3B | 22.78 | A$1.31 | +2.70% |
| NAN.AX | A$3.40 | -1.73% | 1B | 48.57 | A$0.07 | N/A |
| TTX.AX | A$5.09 | +22.36% | 258.4M | -12.72 | -A$0.40 | N/A |
| SDI.AX | A$1.26 | +0.40% | 149.8M | 12.60 | A$0.10 | +2.71% |
| AHC.AX | A$0.38 | -1.30% | 142.4M | 19.00 | A$0.02 | N/A |
| TRJ.AX | A$0.46 | -2.15% | 69.4M | -45.50 | -A$0.01 | N/A |
| OSX.AX | A$0.01 | +0.00% | 2.2M | -0.70 | -A$0.01 | N/A |
Stock Comparison
FPH.AX vs RMD.AX Comparison March 2026
FPH.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPH.AX stands at 18.6B. In comparison, RMD.AX has a market cap of 47.8B. Regarding current trading prices, FPH.AX is priced at A$31.75, while RMD.AX trades at A$32.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPH.AX currently has a P/E ratio of 52.05, whereas RMD.AX's P/E ratio is 23.12. In terms of profitability, FPH.AX's ROE is +0.30%, compared to RMD.AX's ROE of +0.25%. Regarding short-term risk, FPH.AX is more volatile compared to RMD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for FPH.AX.Check RMD.AX's competition here